Ashwagandha root in the treatment of non-classical adrenal hyperplasia

BMJ Case Rep. 2012 Sep 17;2012:bcr2012006989. doi: 10.1136/bcr-2012-006989.

Abstract

Congenital adrenal hyperplasia (CAH) is a well-characterised family of disorders of the adrenal cortices, resulting in varying degrees of cortisol, aldosterone and androgen deficiency or androgen excess, depending on the enzyme(s) affected and the degree of quantitative or functional enzyme deficit. Withania somnifera (WS), commonly known as Ashwagandha, is a medicinal plant that has been employed for centuries in ayurvedic medicine. Preclinical studies have shown that WS increases circulating cortisol levels and improves insulin sensitivity. We report the case of a 57-year-old woman with non-classical adrenal hyperplasia due to both 3-β-ol dehydrogenase deficiency and aldosterone synthase deficiency who was self-treated with WS for 6 months. After 6 months of treatment her serum 18-OH-hydroxycorticoserone, 17-OH-pregnenolone, corticosterone and 11-deoxycortisol decreased by 31%, 66%, 69% and 55%, respectively. The biochemical improvement was accompanied by a noticeable reduction in scalp hair loss.

Publication types

  • Case Reports

MeSH terms

  • 17-alpha-Hydroxypregnenolone / blood
  • Adrenal Hyperplasia, Congenital / blood
  • Adrenal Hyperplasia, Congenital / diagnosis
  • Adrenal Hyperplasia, Congenital / drug therapy*
  • Corticosterone / blood
  • Diagnosis, Differential
  • Female
  • Humans
  • Middle Aged
  • Phytotherapy / methods*
  • Plant Extracts
  • Plant Roots*
  • Withania*

Substances

  • Plant Extracts
  • 17-alpha-Hydroxypregnenolone
  • Ashwagandha
  • Corticosterone